RERG has been found frequently silenced by promoter CpG methylation in nasopharyngeal carcinoma, where it acts as a functional tumor suppressor by suppressing the extracellular signal‐regulated kinase (ERK)/NF-κB signaling pathway [27]. Here, NFKB1 is linked to nasopharyngeal carcinoma.